SCHEMBL5777730

SCHEMBL5777730

COc1ccc(CNc2nc(-n3cncn3)nc3sc4c(c23)CCCC4)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.47
HTT P42858 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
NPSR1 Q6W5P4 2/20 0.47
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 4/20 0.45
GAA P10253 4/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
GLA P06280 2/20 0.45
TSHR P16473 1/20 0.45
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
KCNH2 Q12809 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781373 0.93 MAPT (0.45) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5777938 0.86 MAPT (0.47) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5802113 0.85 MAPT (0.48) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL7129443 0.85 HTT (0.47) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL7126312 0.85 PDE5A (0.59) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5127705 0.84 TNF (0.42) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL5780076 0.84 MEN1 (0.52) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5777372 0.83 PTPN12 (0.45) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5782312 0.83 HTT (0.45) MAPTHTTSMN1; SMN2MEN1KMT2A
SCHEMBL5119295 0.82 TSHR (0.43) MAPTSMN1; SMN2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685136-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005047292-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2005-05-26 WO disclosed
EP-0920431-B1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2003-02-26 EP disclosed
US-6110920-A TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-29 US disclosed
EP-0920431-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 1999-06-09 EP disclosed
WO-1998006722-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed